Announce Date | 05/05/2025 |
EPS Normalized Actual | $4.54 (Beat by $0.36) |
EPS GAAP Actual | $4.54 (Beat by $0.36) |
Revenue Actual | $4.048B |
Revenue Surprise | Beat by $4048M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $5.034 |
EPS GAAP Estimate | $5.034 |
Revenue Estimate | $3.810927437B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 20.28097 | 6.95 | 17.93763 | 22.50973 | 1 |
Dec 2028 | 18.345 | 7.68 | 16.11352 | 21.84116 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 4.83 | 4.83 | 4.048B | 44.99% | 4048M |
FQ4 2024 (Dec 2024) | 3.68 | 3.68 | 3.696B | 40.02% | 3696M |
FQ3 2024 (Sep 2024) | 3.22 | 3.22 | 2.645B | 11.53% | 2645M |
FQ2 2024 (Jun 2024) | 4.69 | 4.69 | 2.483B | 23.64% | 2483M |
FQ1 2024 (Mar 2024) | 0.0043 | 0.0043 | 2.227B | 100% | 2227M |
FQ4 2023 (Dec 2023) | 5.34 | 5.34 | 2.217B | 100% | 2217M |
FQ3 2023 (Sep 2023) | 0.0051 | 0.0051 | 2.34B | 100% | 2340M |
FQ1 2001 (Mar 2001) | 0.0045 | 0.0045 | 2.408B | 100% | 2408M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
5.034
Consensus Revenue Estimates
3.810927437B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.81 | -- | 4.31682 | 5.55514 | 5 |
FQ3 2027 (Sep 2027) | 4.48 | -- | 4.02066 | 5.17402 | 5 |
FQ2 2027 (Jun 2027) | 4.29 | -- | 3.85014 | 4.95458 | 5 |
FQ1 2027 (Mar 2027) | 4.4 | -- | 3.94886 | 5.08162 | 5 |
FQ4 2026 (Oct 2026) | 5.30892 | -- | 4.68036 | 5.82826 | 7 |
FQ3 2026 (Jul 2026) | 5.23533 | -- | 4.61548 | 5.74748 | 7 |
FQ2 2026 (Jun 2026) | 5.38997 | -- | 4.69325 | 5.84743 | 11 |
FQ1 2026 (Mar 2026) | 5.35773 | 9.85 | 4.66518 | 5.81245 | 6 |
FQ4 2025 (Oct 2025) | 5.12998 | 28.26 | 4.5226 | 5.63182 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.46B | -- | 5.03B | 6.12B | 7 |
FQ3 2027 (Sep 2027) | 5.17B | -- | 4.76B | 5.78B | 4 |
FQ2 2027 (Jun 2027) | 4.89B | -- | 4.5B | 5.47B | 4 |
FQ1 2027 (Mar 2027) | 4.62B | -- | 4.26B | 5.17B | 7 |
FQ4 2026 (Oct 2026) | 3.92B | -- | 3.56B | 4.21B | 8 |
FQ3 2026 (Jul 2026) | 3.88B | -- | 3.53B | 4.17B | 5 |
FQ2 2026 (Jun 2026) | 3.73B | -- | 3.36B | 3.98B | 5 |
FQ1 2026 (Mar 2026) | 3.71B | -9.06 | 3.34B | 3.95B | 5 |
FQ4 2025 (Oct 2025) | 3.85B | 4.1 | 3.5B | 4.14B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 4.83 | 4.83 | 100% | |
FQ4 2024 (Dec 2024) | 3.68 | 3.68 | 100% | |
FQ3 2024 (Sep 2024) | 3.22 | 3.22 | 100% | |
FQ2 2024 (Jun 2024) | 4.69 | 4.69 | 100% | |
FQ1 2024 (Mar 2024) | 0.0043 | 0.0043 | 100% | |
FQ4 2023 (Dec 2023) | 5.34 | 5.34 | 100% | |
FQ3 2023 (Sep 2023) | 0.0051 | 0.0051 | 100% | |
FQ1 2001 (Mar 2001) | 0.0045 | 0.0045 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $4.05B | $4048M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.7B | $3696M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.65B | $2645M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.48B | $2483M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.23B | $2227M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.22B | $2217M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.34B | $2340M | 100% |
FQ1 2001 (Mar 2001) | $0B | $2.41B | $2408M | 100% |